| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ALGIL
|
22.10 | 408.5M | 2.11 | 0.62 | 1.11 | 7.0% | 11.6% | 80 | 61 | 58.27 | +122.8% | 73 | 0.16 |
|
LOUP
|
107.60 | 3.8B | 2.94 | 1.44 | 1.27 | 13.7% | 10.0% | 78 | 69 | 249.59 | +99.0% | 83 | 0.27 |
|
SBT
|
9.22 | 577.6M | 5.38 | 1.84 | 2.86 | 7.7% | 10.8% | 76 | 60 | 15.67 | +52.5% | 74 | 0.34 |
|
VRLA
|
19.57 | 2.4B | 12.61 | 2.64 | 1.54 | 8.4% | 7.5% | 65 | 63 | 28.32 | +32.2% | 57 | 2.37 |
|
AKE
|
60.10 | 4.5B | 61.41 | 0.76 | 1.71 | 3.5% | 7.4% | 62 | 56 | 95.38 | +44.0% | 67 | 0.71 |
|
EXPL
|
268.00 | 571.4M | 5.01 | 3.02 | 3.18 | 9.5% | 10.7% | 59 | 42 | 311.80 | +11.8% | 69 | 0.62 |
|
TFF
|
16.64 | 360.5M | 10.24 | 0.74 | 3.20 | -12.1% | 8.4% | 56 | 25 | 22.77 | +21.8% | 55 | 0.79 |
|
CRI
|
8.74 | 211.2M | — | 0.87 | 6.80 | 0.5% | 6.7% | 54 | 50 | 13.82 | +37.2% | 40 | 1.83 |
|
WAGA
|
22.80 | 609.7M | — | 5.47 | — | -3.3% | 9.9% | 23 | 16 | 5.70 | -32.2% | 26 | 1.99 |
|
LHYFE
|
2.10 | 101.3M | — | 4.65 | — | -40.7% | 8.1% | 8 | 6 | — | — | 20 | 5.55 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.